Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia. Joel M. Gottesfeld, James R. Rusche and Massimo Pandolfo. J. Neurochem.(2013) 126 (Suppl. 1), 147–154. DOI: 10.1111/jnc.12302
FULL TEXT PDF
skip to main |
skip to sidebar
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.
Are you looking for truthful information about Friedreich Ataxia?, please start reading this report
Search this blog. Type or paste the DOI or keyword in the box
About Me
- Juan Carlos Baiges
- Tortosa, Catalunya, Spain
- BSc, MSc (Pharmacy), MSc (Computer science)
About me Linkedin
Blog Archive
-
►
2024
(177)
- ► March 2024 (22)
- ► February 2024 (12)
-
►
2023
(218)
- ► December 2023 (18)
- ► October 2023 (23)
- ► August 2023 (18)
- ► February 2023 (22)
-
►
2022
(213)
- ► December 2022 (31)
- ► November 2022 (30)
- ► October 2022 (13)
- ► September 2022 (21)
- ► August 2022 (13)
- ► April 2022 (14)
- ► March 2022 (21)
- ► February 2022 (15)
-
►
2021
(196)
- ► November 2021 (16)
- ► September 2021 (11)
- ► August 2021 (15)
- ► April 2021 (11)
- ► March 2021 (24)
- ► February 2021 (15)
-
►
2020
(200)
- ► December 2020 (21)
- ► November 2020 (20)
- ► October 2020 (23)
- ► September 2020 (17)
- ► August 2020 (16)
- ► April 2020 (15)
- ► March 2020 (16)
- ► February 2020 (11)
-
►
2019
(207)
- ► December 2019 (27)
- ► November 2019 (19)
- ► October 2019 (24)
- ► September 2019 (17)
- ► August 2019 (20)
- ► March 2019 (22)
- ► February 2019 (13)
-
►
2018
(261)
- ► December 2018 (14)
- ► November 2018 (18)
- ► October 2018 (23)
- ► August 2018 (24)
- ► April 2018 (23)
- ► March 2018 (37)
- ► February 2018 (27)
-
►
2017
(215)
- ► December 2017 (26)
- ► November 2017 (14)
- ► October 2017 (24)
- ► September 2017 (17)
- ► August 2017 (19)
- ► April 2017 (17)
- ► March 2017 (15)
- ► February 2017 (11)
-
►
2016
(283)
- ► December 2016 (33)
- ► October 2016 (19)
- ► September 2016 (24)
- ► August 2016 (25)
- ► April 2016 (31)
- ► March 2016 (18)
- ► February 2016 (27)
-
►
2015
(281)
- ► December 2015 (28)
- ► November 2015 (17)
- ► October 2015 (11)
- ► September 2015 (24)
- ► August 2015 (24)
- ► April 2015 (29)
- ► March 2015 (26)
- ► February 2015 (22)
-
►
2014
(278)
- ► December 2014 (26)
- ► November 2014 (21)
- ► October 2014 (22)
- ► September 2014 (20)
- ► April 2014 (32)
- ► March 2014 (17)
- ► February 2014 (24)
-
▼
2013
(315)
- ► December 2013 (16)
- ► November 2013 (29)
- ► October 2013 (24)
- ► September 2013 (32)
- ► August 2013 (21)
-
▼
July 2013
(43)
-
▼
17
(14)
- Clinical features of Friedreich's ataxia: classica...
- Increasing frataxin gene expression with histone d...
- Cardiomyopathy of Friedreich Ataxia
- Erythropoietin in Friedreich ataxia
- Animal and cellular models of Friedreich ataxia
- Frataxin: a protein in search for a function
- Gene regulation and epigenetics in Friedreich's at...
- Prevalence gradients of Friedreich's Ataxia and R1...
- Nikolaus Friedreich and degenerative atrophy of th...
- Deferiprone for the treatment of Friedreich's ataxia
- Co-enzyme Q10 and idebenone use in Friedreich's at...
- Diabetes in Friedreich Ataxia
- Monitoring progression in Friedreich ataxia (FRDA)...
- Mitochondrial pathophysiology in Friedreich's ataxia
-
▼
17
(14)
- ► April 2013 (27)
- ► March 2013 (33)
- ► February 2013 (24)
-
►
2012
(307)
- ► December 2012 (33)
- ► November 2012 (18)
- ► October 2012 (27)
- ► September 2012 (26)
- ► August 2012 (30)
- ► April 2012 (16)
- ► March 2012 (30)
- ► February 2012 (21)
-
►
2011
(251)
- ► December 2011 (19)
- ► November 2011 (25)
- ► October 2011 (18)
- ► September 2011 (23)
- ► August 2011 (16)
- ► April 2011 (26)
- ► March 2011 (19)
- ► February 2011 (18)
-
►
2010
(264)
- ► December 2010 (23)
- ► November 2010 (26)
- ► October 2010 (31)
- ► September 2010 (17)
- ► August 2010 (22)
- ► April 2010 (25)
- ► March 2010 (22)
- ► February 2010 (19)
-
►
2009
(285)
- ► December 2009 (30)
- ► November 2009 (31)
- ► October 2009 (35)
- ► September 2009 (29)
- ► August 2009 (18)